focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCPE.L Regulatory News (CCPE)

  • There is currently no data for CCPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Tender Update

6 Apr 2020 08:32

RNS Number : 8638I
CVC Credit Partners European Opps.
06 April 2020
 

 

6 April 2020

 

CVC Credit Partners European Opportunities Limited

(a closed-ended investment company incorporated in Jersey with registration number 112635)

Registered Office: IFC 1, The Esplanade, St Helier, Jersey, JE1 4BP

 

Quarterly Tender Update

 

CVC Credit Partners European Opportunities Limited (the "Company") has today published its Notice of AGM and annual circular in relation to its contractual Quarterly Tenders (the "Annual Circular"). The Annual Circular sets out the mechanics for the Quarterly Tenders, in line with previous years. However, due to the global spread of Covid-19 (the "Covid-19 Pandemic") and its resultant impact on the day to day liquidity of the assets in the Investment Vehicle, the Board is seeking shareholder approval for additional powers within the Terms and Conditions of the Quarterly Tenders to allow it to be able to respond to any changes relating to the Covid-19 Pandemic in a way that is in the best interests of the Company and the shareholder base as a whole.

 

While the impact of the Covid-19 Pandemic has not, as at the date of this announcement, been severe enough to impair the ability to operate a Contractual Quarterly Tender facility, the situation is evolving rapidly and it is difficult to predict how, and to what degree, the continuing pandemic and the market responses to it directly or indirectly will impact on the Company, the Company Investment Vehicle Interests, the Investment Vehicle and the assets held by the Investment Vehicle.

 

Accordingly, the Board considers it prudent for the terms and conditions of the Contractual Quarterly Tenders for the tenders between June 2020 and March 2021, inclusive, to include additional powers that allow the Board to:

1. reduce the maximum number of Shares that may be tendered for purchase in any quarter below the current limit of 24.99 per cent. of the Shares in issue at the relevant Tender Record Date; and

2. alter the timetable set out in Appendix 1, Section A, or any part thereof prospectively in respect of any quarter or quarters at any time; and

3. suspend the making of any Contractual Quarterly Tender or the completion of any Contractual Quarterly Tender for one or more quarters at any time.

 

The Board intends to use the above powers only where it considers such steps would be in accordance with their duties as directors of the Company, and where using those powers may be necessary, desirable or appropriate to respond to the rapidly developing situation in connection with the Covid-19 Pandemic and its direct or indirect impact on the Company, the Company Investment Vehicle Interests, the Investment Vehicle and the assets held by the Investment Vehicle. Where the Board decides to exercise any of the above powers in relation to the Contractual Quarterly Tender in any quarter, it will make an RIS announcement to the market as soon as practicable thereafter.

 

The Board may utilise the power to reduce the maximum number of Shares that may be tendered for purchase in any quarter more than once in the course of the quarter in order to allow the Board to respond to the impact of changing market conditions on the assets of the Investment Vehicle. The Board will exercise such power in consultation with the Investment Vehicle and after taking into account the liquidity in the assets of the Investment Vehicle. The maximum number of Shares that may be accepted for purchase in any quarter will be confirmed on or around 4 Business Days after the NAV Determination Date for that quarter. The basic entitlement of each Shareholder will also be updated accordingly. Any reduction applied to the number of shares that will be accepted for purchase will be applied pro-rata to the number of shares tendered by each tendering Shareholder.

 

The Board has also decided to remove the right of the Shareholders to roll-over the residual Shares tendered but not purchased in any quarter to the next quarter with priority treatment. Any Shareholders wishing for such residual Shares to be purchased would need to submit a new Tender Request in respect of the subsequent quarter and will be treated in the same way as other Shareholders tendering their Shares in that subsequent Contractual Quarterly Tender.

 

The Board views the withdrawal of the roll-over facility as essential in order to avoid a queue of Tender Requests that stifles the ability of other Shareholders to participate in the tender facility in subsequent quarters.

 

The Board intends to retain the above amendments until the impact of the Covid-19 Pandemic has abated. Upon a return to conditions similar to the period prior to the Covid-19 Pandemic or such other time where the Board considers, in its reasonable opinion and taking into account market conditions, that it is in a position to do so, it will aim to renew the Contractual Quarterly Tender facility at any subsequent AGM thereafter without the above restrictions as soon as practicable.

 

June 2020 Tender

 

As at the date of this announcement, the Board does not anticipate that the Contractual Quarterly Tenders will be able, for the reasonably foreseeable future, to provide the same level of liquidity as they have in previous quarters. Given the current market conditions, the Board is expecting to reduce the maximum number of Shares that may be tendered for purchase in respect of the tender in June 2020. While it is difficult to anticipate how market conditions may change between the date of this announcement and the completion of the June 2020 tender, were the decision being made today the Board believes it likely that it would reduce the size of the June 2020 Tender to c. 10 per cent. of the Shares in issue at the Tender Record Date for the June 2020 Tender. This limit may be subject to further amendments until the date of confirmation of the maximum number of Shares that may be tendered for purchase in relation to the June 2020 Tender as set out in the Annual Circular.

 

The Company will confirm details of the June 2020 tender, including the maximum number of Shares that may be tendered for purchase in due course.

 

Shareholders are encouraged to read in full the Notice of AGM and Annual Circular, which provide more details in relation to the Quarterly Tenders.

 

Unless otherwise defined, capitalised words and phrases in this announcement shall have the meaning given to them in the Notice of AGM and/or the Annual Circular.

 

 

Enquiries:

 

CVC Credit Partners European Opportunities Limited

Richard Boléat

+44 1534 625 522

 

BNP Paribas Securities Services S.C.A. Jersey Branch

+44 1534 709181

 

Winterflood Securities Limited

Joe Winkley/Neil Morgan

+44 20 3100 0000

 

 

 

CVC Credit Partners European Opportunities Limited is regulated by the Jersey Financial Services Commission

This information is provided by RNS

The company news service from the London Stock Exchange

 

 

A copy of this announcement is and will be available, subject to certain restrictions relating to persons resident in restricted jurisdictions, for inspection on the Company's website at www.ccpeol.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TENKKABBOBKKFQK
Date   Source Headline
13th Jun 20223:34 pmRNSChange of Name
9th Jun 20224:50 pmRNSNet Asset Value Weekly to 01 June 2022
1st Jun 20224:46 pmRNSNet Asset Value Weekly to 27 May 2022
1st Jun 202212:43 pmRNSTotal Voting Rights
26th May 20225:22 pmRNSNet Asset Value Weekly to 20 May 2022
19th May 20223:31 pmRNSOrdinary Share Conversion June 2022
19th May 20222:10 pmRNSNet Asset Value Weekly to 13 May 2022
19th May 202211:51 amRNSPublication of the April 2022 Monthly Report
18th May 20224:44 pmRNSDividend Declaration
18th May 20224:43 pmRNSResult of AGM
17th May 20223:19 pmRNSTotal Voting Rights
16th May 20224:31 pmRNSNet Asset Value Month End 29 Apr 2022
13th May 20225:00 pmRNSNet Asset Value Weekly to 06 May 2022
10th May 20223:39 pmRNSMarch 2022 Tender
5th May 20223:24 pmRNSNet Asset Value Weekly to 29 Apr 2022
3rd May 202211:21 amRNSTotal Voting Rights
29th Apr 20222:33 pmRNSTotal Voting Rights
28th Apr 20225:48 pmRNSNet Asset Value Weekly to 22 Apr 2022
28th Apr 20223:43 pmRNSInvestor Call
27th Apr 202212:11 pmRNSHolding(s) in Company
25th Apr 20223:16 pmRNSApril 2022 Share Conversion
22nd Apr 20221:38 pmRNSPublication of the March 2022 Monthly Report
22nd Apr 20221:17 pmRNSNet Asset Value Weekly to 14 Apr 2022
22nd Apr 202210:00 amRNSNotice of AGM
21st Apr 202211:32 amRNSHolding(s) in Company
20th Apr 20223:13 pmRNSMarch 2022 Tender Price
19th Apr 20224:45 pmRNSOrdinary Share Conversion May 2022
14th Apr 20223:58 pmRNSNet Asset Value Weekly to 08 Apr 2022
14th Apr 20223:22 pmRNSNet Asset Value Month End 31 Mar 2022
7th Apr 202212:13 pmRNSNet Asset Value Weekly to 01 Apr 2022
6th Apr 20224:47 pmRNSMarch 2022 Quarterly Tender
6th Apr 202210:17 amRNSAnnual Financial Report
30th Mar 20224:50 pmRNSNet Asset Value Weekly to 25 Mar 2022
24th Mar 20222:49 pmRNSNet Asset Value Weekly to 18 Mar 2022
21st Mar 20224:30 pmRNSOrdinary Share Conversion April 2022
17th Mar 202212:28 pmRNSNet Asset Value Weekly to 11 Mar 2022
16th Mar 20229:01 amRNSPublication of the February 2022 Monthly Report
14th Mar 20221:21 pmRNSNet Asset Value Month End 28 Feb 2022
9th Mar 20224:23 pmRNSNet Asset Value Weekly to 04 Mar 2022
9th Mar 20221:01 pmRNSStrategic Review Update
7th Mar 20224:17 pmRNSHolding(s) in Company
3rd Mar 202212:59 pmRNSNet Asset Value Weekly to 25 Feb 2022
1st Mar 20223:02 pmRNSTotal Voting Rights
24th Feb 20225:31 pmRNSNet Asset Value Weekly to 18 Feb 2022
21st Feb 20221:55 pmRNSPublication of the January 2022 Monthly Report
18th Feb 20224:34 pmRNSHolding(s) in Company
18th Feb 20223:39 pmRNSNet Asset Value Weekly to 11 Feb 2022
18th Feb 20222:28 pmRNSDirector Declaration
18th Feb 202212:04 pmRNSHolding(s) in Company
16th Feb 20225:40 pmRNSNet Asset Value Month End 31 Jan 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.